Kadcyla

FDA

FDA approves new targeted breast cancer drug

WASHINGTON (AP) — The Food and Drug Administration has approved a first-of-a-kind breast cancer medication that targets tumor cells while sparing healthy ones.

02/22/2013

Follow

Get every new post delivered to your Inbox.

Join 28,158 other followers